ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 006,22
0,42%
Dow Jones
44 389,37
0,19%
DAX
21 911,74
0,68%
Brent Oil
75,685
1,43%
Bitcoin
97 278,05
0,81%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Hoth Therapeutics Inc (HOTH)

  7. Hoth Therapeutics Inc (HOTH) Actualités

HOTH

Hoth Therapeutics (HOTH)

Hoth Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:HOTH
DateHeureSourceTitreSymboleSociété
10/02/202514h22PR Newswire (US)Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer TherapeuticNASDAQ:HOTHHoth Therapeutics Inc
07/02/202522h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOTHHoth Therapeutics Inc
07/02/202522h15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:HOTHHoth Therapeutics Inc
24/01/202514h29PR Newswire (US)Hoth Therapeutics Regains Compliance with Nasdaq Listing RequirementsNASDAQ:HOTHHoth Therapeutics Inc
21/01/202514h29PR Newswire (US)Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent ApplicationsNASDAQ:HOTHHoth Therapeutics Inc
17/01/202514h29PR Newswire (US)Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025NASDAQ:HOTHHoth Therapeutics Inc
15/01/202522h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HOTHHoth Therapeutics Inc
08/01/202519h27PR Newswire (US)Hoth Therapeutics Responds to Market Rumors and Shareholder InquiriesNASDAQ:HOTHHoth Therapeutics Inc
07/01/202518h35AllPennyStocks.comShares Of This Micro Cap More Than Doubled TodayNASDAQ:HOTHHoth Therapeutics Inc
07/01/202514h29PR Newswire (US)Hoth Therapeutics Achieves Breakthrough in Phase 2a Trial: HT-001 Delivers 100% Success in Combating Cancer Treatment Skin ToxicitiesNASDAQ:HOTHHoth Therapeutics Inc
26/12/202413h58PR Newswire (US)Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity TreatmentNASDAQ:HOTHHoth Therapeutics Inc
20/11/202413h38PR Newswire (US)Hoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve AssetNASDAQ:HOTHHoth Therapeutics Inc
12/11/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HOTHHoth Therapeutics Inc
29/10/202417h43PR Newswire (US)Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment StudyNASDAQ:HOTHHoth Therapeutics Inc
15/10/202412h38PR Newswire (US)Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now UnderwayNASDAQ:HOTHHoth Therapeutics Inc
17/09/202413h57PR Newswire (US)Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZNASDAQ:HOTHHoth Therapeutics Inc
05/09/202416h32PR Newswire (US)Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a TrialNASDAQ:HOTHHoth Therapeutics Inc
05/09/202414h03PR Newswire (US)Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001NASDAQ:HOTHHoth Therapeutics Inc
16/08/202422h15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HOTHHoth Therapeutics Inc
15/08/202414h04PR Newswire (US)Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer TherapeuticNASDAQ:HOTHHoth Therapeutics Inc
24/07/202416h30AllPennyStocks.comMicro Cap Already Off To The Races At The BellNASDAQ:HOTHHoth Therapeutics Inc
24/07/202412h30PR Newswire (US)Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's TreatmentNASDAQ:HOTHHoth Therapeutics Inc
16/07/202414h31PR Newswire (US)Hoth Therapeutics Expands Clinical Trial for Cancer PatientsNASDAQ:HOTHHoth Therapeutics Inc
18/06/202412h15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:HOTHHoth Therapeutics Inc
18/06/202412h10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HOTHHoth Therapeutics Inc
18/06/202412h07Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:HOTHHoth Therapeutics Inc
10/06/202414h11PR Newswire (US)Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug DiscoveryNASDAQ:HOTHHoth Therapeutics Inc
01/05/202414h00PR Newswire (US)Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024NASDAQ:HOTHHoth Therapeutics Inc
27/03/202419h00PR Newswire (US)Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross ProceedsNASDAQ:HOTHHoth Therapeutics Inc
27/03/202413h27PR Newswire (US)Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity TreatmentNASDAQ:HOTHHoth Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:HOTH

Dernières Valeurs Consultées

EU
ORA
Orange
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
KO
Coca Cola
EU
AI
Air Liquide
EU
BNP
BNP Paribas
EU
AF
Air FranceKLM
EU
BN
Danone
NYSE
NKE
Nike
COIN
SOLUSD
Solana
EU
RNO
Renault
NYSE
MCD
McDonalds
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces